University of Colorado, Denver

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Colorado, Denver sits in the top decile of US sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count).

1,283 total trials 265 currently recruiting 830 completed early-phase tilt top decile by trial count

University of Colorado, Denver: 1,283 sponsored US clinical trials, 265 recruiting.

University of Colorado, Denver sponsors 1,283 registered US clinical trials on ClinicalTrials.gov, 265 of them currently recruiting, and 830 completed. 121 of these trials are in Phase 3-4 (later-stage) and 245 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 23 trials.

Top-decile sponsor footprint

University of Colorado, Denver ranks in the top decile of sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 68/100

830 of 908 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,283 total, page 1 of 26

RECRUITING Phase 2

Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

NCT07125183

RECRUITING Phase 2

Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

NCT07292298

RECRUITING NA

Testing the Impact of the MOHR Follow-up Support

NCT07569224

RECRUITING Phase 1

CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML

NCT07347418

RECRUITING NA

BfedBwell INSPIRE Pilot

NCT07446595

RECRUITING Phase 2

Research On Nicotinamide Riboside Supplement Support in MDS (ROSS Trial)

NCT07579429

RECRUITING Phase 2

Modulation of the Immune System in Down Syndrome for Improved Outcomes and Neurodevelopment - 1

NCT07598643

RECRUITING Phase 3

Exploring Sympathetic Nervous System Function in Individuals With Down Syndrome

NCT07238465

RECRUITING Phase 1

Safety and Tolerability Trial of Psilocybin in Healthy Older Adults

NCT07516405

RECRUITING Phase 2

Cannabidiol and Alcohol Use Disorder Phenotypes

NCT07279558

RECRUITING NA

Psychological Options for Wellness and Recovery (POWeR) Trial for Veterans With Chronic Back/Neck Pain

NCT07137715

RECRUITING Phase 2

NAVIGATE Kidney: A Multi-level Intervention to Reduce Kidney Health Disparities

NCT06810622

RECRUITING NA

Snacking Effects on the Brain Response to Foods and Satiety During Dieting

NCT07428187

RECRUITING NA

Adapting rHIRE and Sleep Monitoring in Parkinson's Disease

NCT07498296

RECRUITING Phase 2

Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

NCT06975111

RECRUITING Phase 2

Equol and Vascular Function in Women With Chronic Kidney Disease

NCT07194590

RECRUITING NA

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

NCT07011147

RECRUITING

Triple EIT (Electrical Impedance Tomography)

NCT07247474

RECRUITING NA

ALERT-ED: Awareness and Linkage to Resources for At-Risk Emergency Department Patients

NCT07028463

RECRUITING NA

Modifying the Geriatric Acute & Post-acute Care Coordination Program for Fall Prevention in the Emergency Department for Telehealth

NCT07034287

RECRUITING Phase 3

Safety and Efficacy of Oral Cannabis in Chronic Spine Pain

NCT05052541

RECRUITING Phase 1

Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis

NCT07030283

RECRUITING Phase 1

A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound

NCT07304024

RECRUITING Phase 1

Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer

NCT06856499

RECRUITING Early Phase 1

Contrast Enhanced Ultrasound in Neurosurgery to Improve Glioma Visualization and Border Demarcation

NCT07050836

RECRUITING NA

Behavioral Weight Loss and Sleep Health Intervention

NCT07255287

RECRUITING Phase 1

Influence of Prosthetic Foot Stiffness on Transtibial Osseointegrated Bone-Anchored Limb Outcomes

NCT07263945

RECRUITING

Colorado Community Engagement Alliance

NCT07440316

RECRUITING NA

Evaluating Mammography Communication Approaches

NCT07228234

RECRUITING NA

Preventing Maternal Mood, Anxiety, and Trauma Symptoms After Cesarean Delivery

NCT06949813

RECRUITING Phase 2

Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors

NCT07001241

RECRUITING NA

CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation

NCT07008911

RECRUITING NA

Multidimensional Sleep Health Intervention to Optimize Concussion Recovery

NCT07082218

RECRUITING

Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D

NCT07005362

RECRUITING NA

Knee Osteoarthritis Rehabilitation Through Rotational Inertia

NCT07424352

RECRUITING Phase 2

Pain Reprocessing Therapy in Post-Operative Knee Pain

NCT06800209

RECRUITING NA

Type 1 Diabetes REst for Metabolic Health

NCT06627504

RECRUITING Phase 4

Study of Large Channel Digital Pancreaticobiliary Scope (DPS) With Compatible Accessories

NCT07120295

RECRUITING NA

Right Ventricular Response to Exercise Among Patients With Chronic Obstructive Pulmonary Disease

NCT07576894

RECRUITING NA

Maternal Left Lateral Position in Fetal Growth Restriction

NCT06919692

RECRUITING NA

Neocortical Microarchitecture of Executive Function

NCT06778135

RECRUITING Phase 4

Safety of Short-course of NSAIDs in Pediatric Patients With CKD

NCT06860711

RECRUITING NA

A Novel Patient Decision Aid for Surgical Treatment Options in Early-Stage Breast Cancer

NCT06813053

RECRUITING NA

Evaluating Changes in Synovial Fluid Before and After GAE for Knee Osteoarthritis

NCT06940479

RECRUITING NA

Spanish-language Executive Function Intervention for Children With Autism and/or ADHD

NCT07084324

RECRUITING NA

The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls

NCT07051668

RECRUITING NA

Shareholder-driven Co-design and Piloting of Spanish Educational Videos About High Yield Pediatric Oncology Topics

NCT07288476

RECRUITING NA

Parent Management Training to Treat Irritability

NCT06020261

RECRUITING Phase 1

NT219 Combined With Standard of Care Biologic Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

NCT06919666

RECRUITING NA

Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men

NCT06912984

Page 1 of 26 Next →

Phase Distribution

PhaseTrial count
Phase 1 114
Phase 2 131
Phase 3 37
Phase 4 84

What is open in the University of Colorado, Denver pipeline

265 recruiting of 1,283 indexed (21% open); 830 completed (65%).

Phase mix: 121 late (III/IV) vs 245 early (I/II) (early-phase heavy).

Top condition: Obesity (23 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Colorado, Denver: open-pipeline peers nationwide

Peers matched on 1,283 registered trials and 21% open enrollment, not the therapeutic-area sidebar.

University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 5%10%15%20%25% Total trials Recruiting share University of Colorado, DenverAstraZenecaUniversity of MichiganUniversity of PittsburghEli Lilly and CompanyCedars-Sinai Medical CenterCraig HospitalW.L.Gore & AssociatesGeorgia Institute of Technology
University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,283 trials (± recruiting share)

Sponsors near 21% open enrollment (± trial volume)

What to do with this University of Colorado, Denver page

1,283 registered trials is a research-attention snapshot, not an endorsement of University of Colorado, Denver or any single study.

  • 265 of University of Colorado, Denver's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition University of Colorado, Denver studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Colorado, Denver pipeline card: 1,283 registered trials from official public datasets.Report a data error.